Mochida Pharmaceutical Co.,Ltd. [4534.T]
TOKYO, Mar 30 (Pulse News Wire) – Mochida Pharmaceutical Co.,Ltd. (4534.T) released its earnings presentation for Q3 FY2026.
7 billion. 2 billion. 6 billion. 6 billion.
Financial results — FY2026/3 (consolidated)
| Metric | Current | YoY |
|---|---|---|
| Revenue | ¥87,487M | +8.4% |
| Operating profit | ¥7,526M | +3.9% |
| Net profit | ¥6,342M | +13.2% |
Next period forecast
Revenue
¥115,500M
+9.8%Op. profit
¥9,500M
+16.9%Net profit
¥8,400M
+47.8%Source: TDNet filing · Figures in millions of yen
🟢 Confidence: High
Note: Financial figures from the earnings presentation have been removed pending correction. For accurate figures, refer to the company's earnings summary (kessan tanshin) filed separately on TDNet.
AI-translated content.